Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8840888 Dosage regimen for administering a CD19XCD3 bispecific antibody

Patent 8840888 was granted and assigned to Micromet on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

Golden AI

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12129300 Antibody variable domains targeting the NKG2D receptor

Edits on 29 Mar, 2024

"update inverses"

Golden AI

edited on 29 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11939384 Antibody variable domains targeting the NKG2D receptor

Edits on 1 Feb, 2024

"update inverses"

Golden AI

edited on 1 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11884733 Antibody variable domains targeting the NKG2D receptor

"update inverses"

Golden AI

edited on 1 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11884732 Proteins binding HER2, NKG2D and CD16

Edits on 7 Dec, 2023

"update inverses"

Golden AI

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer

Edits on 14 Jul, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 14 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08840888 Dosage regimen for administering a CD19XCD3 bispecific antibody US Patent 8840888 Dosage regimen for administering a CD19XCD3 bispecific antibody

Infobox

Patent Number

0884088800

Patent Number

884088800

Edits on 19 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 19 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=0884088800

Edits on 28 Apr, 2023

"Entity importer update"

Golden AI

edited on 28 Apr, 2023

Infobox

Is a

Patent

Current Assignee

Micromet

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

088408880

Date of Patent

September 23, 2014

Patent Application Number

135046650

Date Filed

October 27, 2010

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=088408880

Patent Primary Examiner

‌

Sheela J. Huff

Edits on 24 Sep, 2022

"Entity importer update"

Golden AI

edited on 24 Sep, 2022

Infobox

Is a

Patent

Current Assignee

Micromet

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

088408880

Date of Patent

September 23, 2014

Patent Application Number

135046650

Date Filed

October 27, 2010

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=088408880

Patent Primary Examiner

‌

Sheela J. Huff

Edits on 15 Jun, 2022

"Entity importer update"

Golden AI

edited on 15 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=08840888

Edits on 26 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 26 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08840888 Dosage regimen for administering a CD19XCD3 bispecific antibody

Infobox

Is a

Patent

Current assignee

Micromet

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08840888

Date of patent

September 23, 2014

Patent application number

13504665

Date Filed

October 27, 2010

Patent primary examiner

‌

Sheela J. Huff

Find more entities like US Patent 8840888 Dosage regimen for administering a CD19XCD3 bispecific antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API